These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15730856)

  • 1. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
    Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Exp Hematol; 2005 Mar; 33(3):329-35. PubMed ID: 15730856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
    Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1019-24. PubMed ID: 17065057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
    Horvath Z; Murias M; Saiko P; Erker T; Handler N; Madlener S; Jaeger W; Grusch M; Fritzer-Szekeres M; Krupitza G; Szekeres T
    Exp Hematol; 2006 Oct; 34(10):1377-84. PubMed ID: 16982330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.
    Saiko P; Ozsvar-Kozma M; Bernhaus A; Jaschke M; Graser G; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Int J Oncol; 2007 Nov; 31(5):1261-6. PubMed ID: 17912455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.
    Fritzer-Szekeres M; Savinc I; Horvath Z; Saiko P; Pemberger M; Graser G; Bernhaus A; Ozsvar-Kozma M; Grusch M; Jaeger W; Szekeres T
    Int J Oncol; 2008 Oct; 33(4):887-92. PubMed ID: 18813804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity.
    Saiko P; Pemberger M; Horvath Z; Savinc I; Grusch M; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Oncol Rep; 2008 Jun; 19(6):1621-6. PubMed ID: 18497974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
    Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Fritzer-Szekeres M; Szekeres T
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1541-4. PubMed ID: 15571294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
    Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.
    Saiko P; Horvath Z; Murias M; Handler N; Jaeger W; Erker T; Fritzer-Szekeres M; Szekeres T
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1013-7. PubMed ID: 17065056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.
    Höchtl T; Horvath Z; Bauer W; Karl D; Saiko P; Elford HL; Fritzer-Szekeres M; Szekeres T
    Life Sci; 2004 Jan; 74(9):1071-80. PubMed ID: 14687648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells.
    Szekeres T; Fritzer M; Strobl H; Gharehbaghi K; Findenig G; Elford HL; Lhotka C; Schoen HJ; Jayaram HN
    Blood; 1994 Dec; 84(12):4316-21. PubMed ID: 7994048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
    Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
    Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
    Saiko P; Graser G; Giessrigl B; Lackner A; Grusch M; Krupitza G; Basu A; Sinha BN; Jayaprakash V; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Biochem Pharmacol; 2011 Jan; 81(1):50-9. PubMed ID: 20849828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine.
    Saiko P; Steinmann MT; Schuster H; Graser G; Bressler S; Giessrigl B; Lackner A; Grusch M; Krupitza G; Bago-Horvath Z; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Phytomedicine; 2015 Jan; 22(1):213-22. PubMed ID: 25636891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells.
    Meli M; Tolomeo M; Grifantini M; Mai A; Cappellacci L; Petrelli R; Rotili D; Ferro A; Saiko P; Szekeres T; Dusonchet L
    Int J Oncol; 2011 May; 38(5):1427-36. PubMed ID: 21318222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol induces apoptosis and differentiation in acute promyelocytic leukemia (NB4) cells.
    Cao Y; Wang F; Liu HY; Fu ZD; Han R
    J Asian Nat Prod Res; 2005 Aug; 7(4):633-41. PubMed ID: 16087638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
    Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.
    Madlener S; Illmer C; Horvath Z; Saiko P; Losert A; Herbacek I; Grusch M; Elford HL; Krupitza G; Bernhaus A; Fritzer-Szekeres M; Szekeres T
    Cancer Lett; 2007 Jan; 245(1-2):156-62. PubMed ID: 16488533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.